Evaluation of Acute Toxicity and Early Clinical Outcome in Head and Neck Cancers Treated With Conventional Radiotherapy and Simultaneous Integrated Boost Arc Radiotherapy.

about

Evaluation of Acute Toxicity and Early Clinical Outcome in Head and Neck Cancers Treated With Conventional Radiotherapy and Simultaneous Integrated Boost Arc Radiotherapy.

Item

http://www.wikidata.org/entity/Q47141693

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Evaluation of Acute Toxicity a ...... grated Boost Arc Radiotherapy.

@en

Evaluation of Acute Toxicity a ...... grated Boost Arc Radiotherapy.

@nl

type

Item

label

Evaluation of Acute Toxicity a ...... grated Boost Arc Radiotherapy.

@en

Evaluation of Acute Toxicity a ...... grated Boost Arc Radiotherapy.

@nl

prefLabel

Evaluation of Acute Toxicity a ...... grated Boost Arc Radiotherapy.

@en

Evaluation of Acute Toxicity a ...... grated Boost Arc Radiotherapy.

@nl

P1476

Evaluation of Acute Toxicity a ...... grated Boost Arc Radiotherapy.

@en

P2093

Amit Bahl

http://www.w3.org/2001/XMLSchema#string

Arun Elangovan

http://www.w3.org/2001/XMLSchema#string

Arun S Oinam

http://www.w3.org/2001/XMLSchema#string

Jaimanti Bakshi

http://www.w3.org/2001/XMLSchema#string

Naresh Panda

http://www.w3.org/2001/XMLSchema#string

Roshan Verma

http://www.w3.org/2001/XMLSchema#string

Satinder Kaur

http://www.w3.org/2001/XMLSchema#string

Sudhir Bhandari

http://www.w3.org/2001/XMLSchema#string

Sushmita Ghoshal

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22).

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review.

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

Prospective functional outcomes in sequential population based cohorts of stage III/ IV oropharyngeal carcinoma patients treated with 3D conformal vs. intensity modulated radiotherapy.

Intensity-modulated radiation therapy for head and neck carcinoma.

Fatigue is associated with inflammation in patients with head and neck cancer before and after intensity-modulated radiation therapy.

Hypopharyngeal squamous cell carcinoma: Three-dimensional or Intensity-modulated radiotherapy? A single institution's experience

Real-life assessment of Volumetric Modulated Arc Therapy (VMAT) toxicity in Head and Neck Squamous Cell Carcinoma (HNSCC) treatment.

P304

117-121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14740/WJON1049W

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29147446

http://www.w3.org/2001/XMLSchema#string

P932

5650008

http://www.w3.org/2001/XMLSchema#string